Why The CDC’s Vaccine Committee Won’t Meet This Week

In this week’s edition of InnovationRx, we look at Roche’s big AI drug development bet, an E. coli outbreak in raw milk cheddar, R1 Therapeutics’ $78 million raise, and more.

U.S. Cleantech Rollbacks Hurt Both The Climate And Your Wallet

his week’s Current Climate newsletter also looks at Tesla’s best business bet and accelerating the shift from fossil fuels for stability and energy security

Building The Power Grid For Space-Based Data Centers

How a new startup plans to power satellites with lasers. A new class of ultrafast AI chips also uses lasers. And startup Axiomatic AI is building better AI models for science and engineering.

The World’s Richest Healthcare Billionaires

In this week’s edition of InnovationRx, we look at the richest five healthcare billionaires, Lilly’s first big AI success, Science Corp.’s brain implants, and more.

Turning Idle California Farmland Into A Clean Energy Powerhouse

This week’s Current Climate newsletter also looks at how data centers are driving clean energy adoption and Rivian-backed ALSO’s plan to shake up the global e-bike market

Startup Loft Orbital Is Launching AI-Powered Satellites This Fall

Building space-based AI. Designing new molecules with quantum computers. Why pink noise is bad for your sleep. All that and more in this week’s edition of The Prototype.

Novartis And Henrietta Lacks’ Family Reach A Settlement

In this week’s edition of InnovationRx, we look at the startup that wants to treat Alzheimer’s with microrobots, medical groups push back on RFK’s vaccine changes and more.

Data Center Batteries Enter The Iron Age

This week’s Current Climate newsletter also looks at how Red Texas is turning green when it comes to energy and building up U.S. supply chains for a better electric grid

The Startup Building An Operating System For Biotech AI

Building an AI infrastructure for biotech. Bacteria that munch on cancer. How to best make a cold brew. All that and more in this week’s edition of The Prototype.

This Looming Drug Development Gap Could Impact Patients’ Health

In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.